Pathogenesis and etiology of cutaneous NK/T lymphoproliferative disorders
皮肤 NK/T 淋巴细胞增殖性疾病的发病机制和病因学
基本信息
- 批准号:11670843
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In order to elucidate the EBV gene expression, we examined 8 patients with cutaneous EBV-related NK/T-cell lymphomas, including 6 patients with NK-cell phenotypes and 2 patients with T-cell phenotypes. All samples from the patients contained EBV nuclear antigen(EBNA)-1 mRNA which was transcribed using the Q promoter, whereas both the Q promoter and another upstream promoter (Cp/Wp) were used in 3 EBV-positive cell lines, B95.8, Raji and Jiyoye. Latent membrane protein-1 (LMP-1) mRNA was detected in 7 out of 8 patients and all cell lines, whereas EBNA-2 transcripts were found only in the cell lines. The BHRF1 (viral bcl-2 homologue) and BCRF1 (viral interleukin(vlL)-10) gene transcripts were detected in 1 (NK2) and 2 patients (NK2 and 3), respectively. The patient (NK2) with UK-cell lymphoma expressing the both transcripts died of rapid progression of the illness. No LMP-1, EBNA-2 or ZEBRA antigens were detected in the skin lesions by immunostaining although they were positive in the cell line cells.One EBV-infected NK cellI line designated NOY-1 was established from a patient with hypersensitivity to mosquito bite associated with oligoclonal proliferation of EBV-infected NK cells in the blood. Clonal expansion of the cells was observed in the cutaneous lesions following mosquito bite. The cell line cells contained 7.5 copies of EBV-DNA, and produced high levels of IFN-gamma by stimulation.
为了阐明EBV基因的表达,我们检查了8例皮肤EBV相关的NK/T细胞淋巴瘤,包括6例NK细胞表型和2例T细胞表型患者。来自患者的所有样品均含有使用Q启动子转录的EBV核抗原(EBNA)-1 mRNA,而Q启动子和另一上游启动子(Cp/Wp)均用于3种EBV阳性细胞系B95.8、Raji和Jiyoye中。在8例患者中的7例和所有细胞系中检测到潜伏膜蛋白-1(LMP-1)mRNA,而EBNA-2转录物仅在细胞系中发现。BHRF 1(病毒bcl-2同源物)和BCRF 1(病毒白细胞介素(vIL)-10)基因转录本分别在1例(NK 2)和2例(NK 2和3)患者中检测到。患有表达两种转录物的UK细胞淋巴瘤的患者(NK 2)死于疾病的快速进展。免疫组化结果显示,LMP-1、EBNA-2和ZEBRA抗原均为阳性,但在皮损中均未检测到。在蚊虫叮咬后的皮损中观察到细胞的克隆性扩增。该细胞系细胞含有7.5拷贝的EBV-DNA,并通过刺激产生高水平的IFN-γ。
项目成果
期刊论文数量(34)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Satoh M, Oyama N, Akiba H, Ohtsuka M, Iwatsuki K, Kaneko F: "Hypersensitivity to mosquito bites with natural-Killer cell lymphocytosis : the possible implication of Epstein-Barr virus reactivation"Eur J Dermatol. 12. 381-384 (2002)
Satoh M、Oyama N、Akiba H、Ohtsuka M、Iwatsuki K、Kaneko F:“自然杀伤细胞淋巴细胞增多对蚊虫叮咬过敏:EB 病毒重新激活的可能影响”Eur J Dermatol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Iwatsuki Keiji,: "Cutaneous lymphoproliferative disorders associated with Epstein Barr virus infection : a clinical overview"Journal of Dermatological Science. 22. 181-195 (2000)
Iwatsuki Keiji,:“与 Epstein Barr 病毒感染相关的皮肤淋巴增殖性疾病:临床概述”皮肤病学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Iwatsuki Keiji: "Unusual Lymphomas"Gunter Burg(印刷中).
Keiji Iwatsuki:“异常淋巴瘤”Gunter Burg(正在出版)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
N. Oyama, K. Iwatsuki, Y. Homma, F. Kaneko: "Induction of transcription factor AP-2 by inflammatory cytokine in human keratinocytes."J Invest Dermatol.. 113. 600-606 (1999)
N. Oyama、K. Iwatsuki、Y. Homma、F. Kaneko:“人角质细胞中炎症细胞因子诱导转录因子 AP-2。”J Invest Dermatol.. 113. 600-606 (1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Iwatsuki Keiji 他: "Treatment of recurrent auricle pseudocyst with intralesional injection of minocycline : A report of two cases"Journal of the Academy of Dermatology. 45・4. 554-556 (2001)
Iwatsuki Keiji等:“病灶内注射米诺环素治疗复发性耳廓假性囊肿:两例报告”皮肤科杂志45・4(2001年)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IWATSUKI Keiji其他文献
IWATSUKI Keiji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IWATSUKI Keiji', 18)}}的其他基金
Molecular and cytological markers related to the development and prognosis of EB virus-associated lymphoproliferative disorders
与 EB 病毒相关淋巴增殖性疾病的发生和预后相关的分子和细胞学标志物
- 批准号:
15K09744 - 财政年份:2015
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on host immune responses induced by reactivation of EB virus-infected lymphocytes and resultant skin lesions
EB病毒感染的淋巴细胞再激活诱导的宿主免疫反应及由此产生的皮肤损伤的研究
- 批准号:
24591653 - 财政年份:2012
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Preferable biological milieu for the growth of viral epithelial neoplasms and its regulation
病毒上皮肿瘤生长及其调节的优选生物环境
- 批准号:
22659205 - 财政年份:2010
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
A disease spectrum induced by EB virus latent infections and the pathogenesis
EB病毒潜伏感染引起的疾病谱及其发病机制
- 批准号:
20390307 - 财政年份:2008
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Pathogenesis and Prognosis of Skin Diseases Caused by Host Immune Responses against EB virus Latent Infections
EB病毒潜伏感染宿主免疫反应引起皮肤病的发病机制及预后
- 批准号:
17390311 - 财政年份:2005
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A STUDY ON PATHOGENESIS AND PROGNOSIS OF EPSTEIN-BARR VIRUS-ASSOCIATED CUTANEOUS LYMPHOPROLIFERATIVE DISORDERS
爱泼斯坦-巴尔病毒相关皮肤淋巴增殖性疾病的发病机制和预后研究
- 批准号:
14370261 - 财政年份:2002
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Optimisation of small molecule inhibitors for effective targeting of phospholipase C gamma in T-cell lymphoma
优化小分子抑制剂以有效靶向 T 细胞淋巴瘤中的磷脂酶 C γ
- 批准号:
MR/Y503344/1 - 财政年份:2024
- 资助金额:
$ 2.24万 - 项目类别:
Research Grant
Selective targeting of a Rho GTPase mutant for peripheral T cell lymphoma treatment
选择性靶向 Rho GTPase 突变体治疗外周 T 细胞淋巴瘤
- 批准号:
10721439 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Examination of the involvement of IL-26 in cutaneous T-cell lymphoma
IL-26 参与皮肤 T 细胞淋巴瘤的研究
- 批准号:
23K15263 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
PD-1 tumor suppressor mechanims in peripheral T-cell lymphoma
PD-1在外周T细胞淋巴瘤中的抑癌机制
- 批准号:
10581151 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Clinical and Genetic Origins of Monomorphic Epitheliotropic Intestinal T Cell Lymphoma
单形性上皮性肠 T 细胞淋巴瘤的临床和遗传起源
- 批准号:
10566317 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
The Role of IL-15 in Cutaneous T-cell Lymphoma Progression
IL-15 在皮肤 T 细胞淋巴瘤进展中的作用
- 批准号:
10737322 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Elucidation of the landscape of genetic alterations and their biological relevance in extranodal NK/T cell lymphoma, nasal type.
阐明鼻型结外 NK/T 细胞淋巴瘤的遗传改变及其生物学相关性。
- 批准号:
23K15313 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Genomic biomarkers for cutaneous T-cell Lymphoma
皮肤 T 细胞淋巴瘤的基因组生物标志物
- 批准号:
10550139 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Elucidating transcriptional and epigenetic regulators of aggressive cutaneous T cell lymphoma
阐明侵袭性皮肤 T 细胞淋巴瘤的转录和表观遗传调节因子
- 批准号:
10389198 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Role of S.aureus in Cutaneous T Cell Lymphoma Pathogenesis
金黄色葡萄球菌在皮肤 T 细胞淋巴瘤发病机制中的作用
- 批准号:
10620254 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:














{{item.name}}会员




